INTRODUCTION
Rheumatoid factors (RF)1 of the ,-, y-, and a-isotypes have been well documented in rheumatoid arthritis (RA) and other conditions (1) (2) (3) . Interest in the possible existence of RF of the E-isotype is due to the ability of IgE antibodies to bind to and trigger mast cells and basophils. Suggestive evidence that IgE-RF might exist was presented in 1969 by Broder et al. (4) who described an apparent immune complex in the serum of many patients with RA that cauised the release of histamine from isolated perfused guinea pig lung.
IgE-RF then could focus an array of inflammatory mediators at a site containing basophils or mast cells and an appropriately high epitope density of IgG. To look for IgE-RF, we have developed a solid-phase radioimmunoassay (RIA) for its detection. In this paper we present evidence of the specificity of our assay, and results of the screening of sera from patients with RA, asthma, and several other diseases possibly mediated by immunologic mechanisms, some of which indeed contained IgE-RF activity. p.l of serum diluted 1:10 in 5% NCS-BBS was added to each well. After an overnight incubation at 40C in a humidified box, the plates were washed five times with 250 ,ul of BBS and the amount of IgE protein bound to each well detected by the addition of 100 ,Al of affinity-purified l25I-labeled GAHE at a concentration of200 ng/ml. After a final 3-h incubation at room temperature, the plates were washed 10 times, the wells cut, and the radioactivity of the individual wells counted on an automatic gamma counter.
METHODS
Analysis ofresults. All values are arithmetic means unless stated otherwise. Statistical analyses were performed by Student's t test with logarithmically transformed data. Correlation coefficients were generated by least-squares regression analysis using logarithmically transformed data.
RESULTS
Specificity of the RIA. The specificity of the GAHE antibody has been described (7), and was confirmed for this assay. The binding of 125I-GAHE in the last step of the RIA was specifically inhibited by the addition of IgE(PS) but not by IgG, IgA, or-IgM protein (Fig. 1) . IgE (For), which has a K-light chain, also inhibited the binding (data not shown). Furthermore, serum shown to contain IgE-RF activity was passed three times over either a GAHE-Sepharose column (to deplete the IgE) or a Bence Jones light chain-Sepharose column (as a control). The IgE-RF activity was totally removed in the GAHE-Sepharose column effluent, but was not significantly changed in the light chain-Sepharose column effluent compared to the original serum. Latex titers in both column effluents were unchanged from the original serum.
The specificity of the binding of IgE-RF to IgG is shown in Fig. 2 Of 20 sera from patients with seropositive RA, 18 were positive for IgE-RF activity. This was a highly significant difference compared with the control group (P < 0.001). One of four patients with seronegative RA was positive for IgE-RF. Fig. 3 shows these sera as well as the control sera plotted as IgE-RF activity vs. latex titer. There was a positive correlation between IgE-RF levels and the latex titers (r = 0.776), although there were instances of positive latex titers and negative IgE-RF levels, and vice versa.
The independence of IgE-RF from IgM-RF was confirmed using sera from three patients with RA and high IgE-RF levels. Each aliquot of serum was depleted of IgE by passage three times over a GAHE-Sepharose column, then diluted with exogenous IgE protein. In all cases the IgE-RF activity in the effluent was removed by the adsorption, and was not recovered by adding back either IgE(PS) protein or IgE containing serum from either a normal donor or an asthmatic with elevated serum IgE. Furthermore, the eluants contained all of the original IgE-RF activity, and were negative in the latex test.
3 of 32 patients with asthma were positive for IgE-RF -all 3 had low levels of latex positivity, 2 of the 3 appeared to have an allergic component to their asthma and polyarthralgias. One patient with hypocomplementemic vasculitis, iodide sensitivity, and polyarthralgias also had an elevated IgE-RF level. The remaining patients tested, including SLE, Sjogren's syndrome, urticarialangioedema, and mixed cryoglobulinemia, were all negative for IgE-RF activity. 
DISCUSSION
Results presented in this paper clearly document the existence of IgE-RF. The specificity of the assay in detecting only IgE, as well as the specificity ofthe binding of the IgE-RF to IgG, were shown. IgE-RF activity was shown to be independent of total seruim IgE concentration.
Two recent papers have reported IgE-RF (10, 11) . IgE concentrations in serum are four to five orders of magnitude less than that of IgM or IgG, and so great care has to be used to prove that the assay does in fact measure IgE; however, neither of the prior papers established the specificity of their assays. One group (10) estimated IgE-RF by measuring total IgE levels before and after adsorption with insolubilized IgG in normal employees receiving regular gamma globulin injections, but the error inherent in their indirect assay was close enough to their results to make their conclusions tentative. The other group (11) used a direct assay to measure IgE-RF in patients with RA, but their assay was 1,000 times less sensitive than our assay. This is reflected in their detecting lgE-RF in only 4 patients out of 109 with RA.
We found 18 of 20 patients with RA to have IgE-RF. The two negative results were from patients with minimally active disease. One patient of four with seronegative RA had IgE-RF (similar to the percentage of IgG-and IgA-RF reported in seronegative RA) (12), and she had severe erosive disease.
3 of 32 patients with asthma were found to have IgE-RF as was 1 patient with hypocomplementemic vasculitis and iodide sensitivity. All four of these patients had complaints of polyarthralgias and low levels of latex positivity. Seven patients with angioedema/urticaria, three with SLE, and one each with Sjogren's syndrome and mixed cryoglobulinemia were negative for IgE-RF activity despite variable and often high latex titers.
The synovium contains large numbers of mast cells (13) and is freely exposed to circulating basophils because of its vascularity. In RA self-aggregating IgG complexes are found in the synovial tissue and space (14, 15) . We hypothesize therefore that IgE-RF could bind to the aggregated IgG and be bound to receptors on the mast cell/basophil. The resulting release of mediators would lead to an intense inflammatory reaction and f:avorable conditions for fibroblast proliferation in the joint.
The etiology and pathogenesis of rheumatoid arthritis have eluded any simple unifying explanation (16, 17 
